BRIEF published on 08/18/2025 at 12:35, 1 year ago China Unicom propulse les jeux de robots humanoïdes au niveau supérieur grâce à son réseau 5G-A avancé Technologie De L'IA China Unicom Robots Humanoïdes Réseau 5G-A Jeux De Robots
PRESS RELEASE published on 08/18/2025 at 12:30, 1 year ago China Unicom Beijing Powers World's First Humanoid Robot Games with Smart 5G-A Network China Unicom Beijing provides cutting-edge 5G-A network coverage at 2025 World Humanoid Robot Games, enhancing robot performance and spectator experience Technology Artificial Intelligence 5G-A Network China Unicom Beijing Humanoid Robot Games
Published on 09/11/2026 at 04:00, 3 hours 13 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 8 hours 48 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 15 hours 53 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 16 hours 13 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 00:05, 7 hours 8 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 7 hours 12 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 8 hours 33 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 2 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 9 hours 6 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 13 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 13 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 11 hours 43 minutes ago Availability of the 2026 Interim Financial Report
